SAM
GH icon

Silvercrest Asset Management’s Guardant Health GH Stock Holding History

Silvercrest Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,404
Closed -$214K – 856
2021
Q1 		$214K Buy
+1,404
New +$212K ﹤0.01% 796

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Silvercrest Asset Management's GH Position: Q2 2021 in Review

Silvercrest Asset Management sold out of Guardant Health (GH) in Q2 2021, closing a stake of 1,404 shares — an estimated $214K sold.

Silvercrest Asset Management first reported a position in GH in Q1 2021 and held it in 1 quarter. The position peaked at $214K in Q1 2021. 416 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Silvercrest Asset Management reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Silvercrest Asset Management sold 1,404 Guardant Health shares in Q2 2021, an estimated $214K.
  • Silvercrest Asset Management first reported a position in Guardant Health in Q1 2021 and held it in 1 quarter.
  • Silvercrest Asset Management's Guardant Health position peaked at $214K in Q1 2021.
  • 416 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Silvercrest Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.